Abstract
169TiP Tocilizumab, ipilimumab, and nivolumab for the treatment of advanced melanoma, non-small cell lung cancer, or urothelial carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have